McDermott Will & Emery represented Pasithea Therapeutics Corp. in the transaction. Pasithea Therapeutics Corp., a biotechnology company focused on the discovery, research and development of innovative...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery represented Mullen Automotive, Inc. in the transaction. Mullen Automotive, Inc. (NASDAQ: MULN), an emerging electric vehicle (EV) manufacturer, announced its acquisition of a...
You must be a Standard 1 Year member to access this content.
McDermott Will and Emery represented Portage Biotech Inc. in the transaction. Portage Biotech Inc., a clinical-stage immuno-oncology company developing therapies to improve patient lives and increase...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery represented Pasithea Therapeutics Corp. in the transaction. Pasithea Therapeutics Corp. (Pasithea), a US biotechnology company focused on the research and discovery of...
You must be a Standard 1 Year member to access this content.
Centerline Biomedical, Inc., a private medical technology company, closed $33 million Series B equity financing, led by Cleveland Clinic, a nonprofit multispecialty academic medical center that integrates clinical...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery represented Compagnie Générale des Établissements Michelin SCA (Michelin) in the transaction. Cleary Gottlieb represented Altaris Capital Partners in the transaction. Compagnie Générale...
You must be a Standard 1 Year member to access this content.
